Fingerprint
Dive into the research topics of 'Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh
Research output: Contribution to journal › Article › peer-review